MetP Pharma is a company that develops a nasal drug delivery platform. It is designed to promote the administration of systemic-acting drugs with low oral bioavailability and drugs that are difficult to deliver via routes other than injection. The company provides Lecticula, a mono-dose device for the nasal application of drugs.